|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Erratum: Vol. 45, No. RR-12In the MMWR Recommendations and Reports entitled "Update: Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions -- Recommendations of the Advisory Committee on Immunization Practices (ACIP)," the first complete paragraph on page 10 should read: "OPV should not be administered to persons who have experienced an anaphylactic reaction to a previous dose of OPV." The next paragraph should read: "IPV should not be administered to persons who have experienced a) an anaphylactic reaction following a previous dose of IPV or b) an anaphylactic reaction to streptomycin, polymyxin B, or neomycin." Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|